Can an iPhone app keep cancer patients safer during chemo?

NCT ID NCT06106360

Recruiting now Knowledge-focused Sponsor: Inova Health Care Services Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether cancer patients undergoing chemotherapy can use an iPhone app and Apple Watch to report symptoms from home. Researchers will enroll 100 adults with solid tumors or blood cancers to see if they can consistently use the technology. The goal is to learn if remote monitoring is practical and how often patients should be asked about their symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Locus Health iPhone App and Apple Watch
What this could lead to: If successful, this could show that remote monitoring is feasible for cancer patients, potentially leading to better symptom management and reduced hospital visits.
What could go wrong: This is a small pilot study with only 100 participants, so results may not apply to all patients. It focuses on feasibility, not on improving health outcomes directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGICAL MALIGNANCY SOLID TUMOR

Contacts and locations

Locations

Inova Schar Cancer Institute
RECRUITING

Fairfax, Virginia, 22031, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.